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Background
The underlying myocardial injury in early forms of
dilated cardiomyopathy (DCM) is unclear. Cardiovascu-
lar magnetic resonance (CMR) myocardial T1-mapping
monitors the enlargement of the cardiac extra-cellular
space and thus offers a non-invasive tool of quantitative
measurement of myocardial fibrosis. We used T1-
mapping techniques to explore the hypothesis that
diffuse myocardial fibrosis is related to DCM.
Methods
We investigated 77 DCM patients (55 ± years, 51 males)
and 46 healthy controls (52 ± years, 23 males). Significant
coronary artery disease was excluded invasively. All CMR
examinations were performed using 1.5 T CMR scanner
(Philips Achieva). Short axis slices covering the LV were
acquired using SSFP sequence to measure volumes and
ejection fraction. T1-relaxation times were measured
before and 15 minutes after Gd-DTPA (Magnograf) injec-
tion (0.2 mmol/kg). T1-maps were created out of 11 mid-
ventricular short axis views with increasing inversion
times (TI;100 - 4400 msec.) using a single breath-hold
modified Look Locker inversion recovery sequence
(MOLLI, TR/TE=3.5/1.8 msec, flip angle = 35°) in late dia-
stole. Early DCM with mild reduction of LVEF was
defined as EF between 45-55% while severely depressed
LVEF was defined as EF<30%. Delta-T1 was calculated as
non-contrast myocardial T1-post-contrast myocardial T1.
Results
Mean LVEF was 43 ± 12% in DCM and 62 ± 4 in controls.
Compared to controls, deltaT1 was significantly higher in
42 early DCM patients (588 ± 60 ms; vs. 490 ± 220ms;
p=0.006). Patients with advanced DCM (n=10) had the
highest delta-T1-values (634 ± 71 ms). Non-contrast-T1
(371 ± 164 ms vs. 399 ± 41 ms; p =ns) and post-contrast-
T1 (1018 ± 40 ms vs. 1037 ± 45 msp=ns) were not signifi-
cantly different between controls and patients with
advanced DCM. ANOVA analysis showed significant dif-
ferences between the groups (p<0.002, Figure 1). There
was no significant association between the presence of late
gadolinium enhancement (LGE) and the severity of LV
dysfunction (31% of the patients in early DCM and 45% in
severely depressed EF group; p=0.5). No significant differ-
ences in T1-values (non-contrast-, post-contrast- or delta-
T1) between moderately and severely depressed EF were
found (p=0.9).
Conclusions
Diffuse myocardial fibrosis commences already at an
early disease stage of DCM when LVEF is only mildly
reduced. In contrast to focal fibrosis seen in LGE, diffuse
fibrosis is more linked to the severity of LV dysfunction.
Importantly, the differences between T1-values before
and after contrast administration (delta-T1) appear to be
a more reliable parameter in the assessment of myocar-
dial fibrosis than a single time-point measurement.
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